Home › Funds › Dauntless Investment Group, LLC › QNRX

Dauntless Investment Group, LLC position in QNRX

QUOIN PHARMACEUTICALS LTD · Health Care

Dauntless Investment Group, LLC reported holding 214,987 shares of QNRX (QUOIN PHARMACEUTICALS LTD) in its Q2 2026 13F filing — a position valued at US$1.0M, representing 0.82% of its reported portfolio and ranking #25 among its reported holdings. Dauntless Investment Group, LLC has disclosed QNRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)214.99K sh
Reported value held$1.04M
Portfolio Weight0.82%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Dauntless Investment Group, LLC's QNRX position evolved

Dauntless Investment Group, LLC first disclosed a stake in QNRX in Q1 2026 at 196,592 shares (US$1.3M). Across 2 filings, Dauntless Investment Group, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 214,987 shares valued at US$1.0M — an increase of 18,395 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 196.59K $1.30M New
Q2 2026 214.99K $1.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QNRX and 13F data

QNRX (QUOIN PHARMACEUTICALS LTD) is a Health Care company. 20 other funds we track also report a position in QNRX — the largest reported positions include Stonepine Capital Management, LLC (US$966K), AIGH Capital Management LLC (US$339K), Velan Capital Investment Management LP (US$157K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QNRX

All QNRX fund holders →

FAQ

How long has Dauntless Investment Group, LLC held QNRX?

Dauntless Investment Group, LLC has disclosed QNRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Dauntless Investment Group, LLC's current position in QNRX?

As of Q2 2026, Dauntless Investment Group, LLC holds 214.99K shares of QNRX (QUOIN PHARMACEUTICALS LTD), valued at $1.04M, representing 0.82% of its reported portfolio and ranking #25.

Has Dauntless Investment Group, LLC been buying or selling QNRX?

In the latest 13F filing (Q2 2026), Dauntless Investment Group, LLC increased its position in QNRX.

Which other funds hold QNRX?

Other major institutional holders of QNRX include Stonepine Capital Management, LLC, AIGH Capital Management LLC, Velan Capital Investment Management LP, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.